Stocks to sell

There are some solar stocks to sell that I believe will disappoint investors with their results. These companies are standing on shaky ground, with near-term headwinds battering their fundamentals and valuations. Investors should carefully consider the solar stocks to sell in this article. I believe there are far better opportunities for investors elsewhere. Here, I

Electric vehicle stocks haven’t faired as well to the start of 2024 leading to EV stocks to sell. Slowing sales, high valuations and rising net losses have made some EV stocks vulnerable to crashes.  Some investors may interpret a 70% decline as a good buying opportunity. However, not every stock is a buy-the-dip opportunity just

The AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) has surged by nearly 30% year-to-date, showcasing the rejuvenated demand for cannabis stocks. Salient to the ETF’s year-to-date performance has been the increased popularity of high-beta securities. Moreover, many anticipate that marijuana will soon be downgraded to a Schedule II category substance from its current Schedule I status,

The stock markets have been on a hot run for many months on the back of renewed enthusiasm due to rates and the continued run in artificial intelligence (AI). Undoubtedly, last week’s consumer price index number was a bit of a setback. But, markets managed to move on from the disappointing (and a tad overheated)

Rewind a few weeks ago and the general consensus was much more optimistic regarding potential rate Cuts in March. then the Federal Reserve all but shut down that notion after unanimously voting to leave rates on changed at their early February meeting. This is leading to ever-changing interest rate expectations. The Federal Reserve will need greater

The stock market has had a good rally since the third quarter of 2023. Despite a downturn in January, major market indices, including the S&P500 and Nasdaq, are trading upward, adding to the significant gains accrued last year. This has, in turn, led to a rapid rise in the valuations of several stocks. If investors

Dividend investing has proved to be among the most successful ways to accumulate wealth on Wall Street. Buying dividend stocks that grow their payout produces returns far above what non-dividend-paying stocks generate. Yet you should only buy those companies that can support their dividends. Southern Copper (NYSE:SCCO) just announced it was slashing its payout 20%.

Down 25% so far this year, the Tesla (NASDAQ:TSLA) stock outlook isn’t fantastic. The company looks to be at the beginning of a long-term decline as the company loses market share amidst growing competition in the electric vehicle space. Tesla was the sole mass producer of fully electric vehicles for over a decade. Tesla sold

The Dow Jones Industrial Average is near record highs as the stock rally that began in spring 2023 continues. Comprised of 30 leading blue-chip stocks that are representative of the U.S. economy, the index is often referred to as the “Dow 30.” While the index might be at record levels, it has reached those heights

February means Valentine’s Day and romance. But if you’re stubbornly holding F-rated stocks to sell in your portfolio, you’re just setting yourself up for heartbreak. The stock market is off to a solid start this year, with the Dow Jones Industrial Average up 2%, the S&P 500 index up nearly 5%, and the tech-heavy Nasdaq

The stock market rally that began in earnest last spring is starting to get frothy. Some stocks are now making parabolic moves and rising at what appear to be unsustainable rates. Speculation in the market appears to have returned, with cryptocurrencies also rising sharply in recent weeks and now at their highest levels in two

When it comes to EV stocks to sell, there are the Haves and Have Nots. The Haves make money from their EV businesses. The Have Nots lose money. It’s much easier to recommend stocks to sell from the Have Nots than those to buy from the Haves. Even a company like Tesla (NASDAQ:TSLA), which is

Advanced Micro Devices (NASDAQ:AMD) shares have skyrocketed in price over the past twelve months. AMD stock has surged by 106.8% during this timeframe. Riding the AI wave has been profitable, but now may not be the right time to enter. Nor is it a good reason to “let it ride,” on the view that the

Without a doubt, the meme-stock craze is over for the most part. Nearly all of the former meme favorites, from Gamestop (NYSE:GME) to Ocugen (NASDAQ:OCGN) to Vinco Ventures (OTC:BBIG), have lost the lion’s share of their peak values and are currently struggling, both from a fundamental perspective and in terms of their stock prices. Still,

2024 might be the year space stocks break through years of shakiness and pre-revenue indecision. Already, we’re seeing major companies like SpaceX, Rocket Lab USA (NASDAQ:RKLB), and AST SpaceMobile (NASDAQ:ASTS) rack up win after win. We’re even seeing companies like Amazon (NASDAQ:AMZN) enter the space race through its Kuiper Systems initiative. But, though space stocks

The AMD (NASDAQ:AMD) stock outlook may be fading. has doubled in the last year, and investors are turning increasingly bullish on their AI chip prospects in 2024. The company plans to release their MI300 AI chips, forecasting between $2-$4 billion in sales in the 2024 fiscal year.  While this is great news, AMD has yet

February triggered a rollercoaster ride through the stock market’s twists and turns. Amidst the cacophony of growth stocks to sell, three names echo the market with a hint of fundamental caution. Once labeled castles of value potential, these growth stocks stand at a dangerous crossroads. From the bustling aisles of automotive retail to the lofty

The banking system has run into a fresh crisis, leaving several bank stocks to sell. Shares of New York Community Bancorp (NYSE:NYCB) plunged recently following a massive earnings miss and credit rating downgrade. This unleashed broader concerns about the state of the American regional banking system, particularly regarding credit quality and loans in the commercial

The unpredictable nature of the biotech industry, which frequently flirts with failure, underscores the inherent risks and rewards associated with doomed biotech stocks. The journey from drug discovery to market approval is notoriously long and uncertain. The road often exceeds a decade, with the approval process varying significantly by drug type. This complexity, coupled with

The Senate Judiciary Committee’s recent hearing has intensified the scrutiny on social media giants, including Meta Platforms (NASDAQ:META) and TikTok, painting a grim reality of the platforms’ impacts on youth. As the legislative hammer looms with potential regulations, the sentiment to dispose of social media stocks to sell grows. With heart-wrenching accounts from parents whose children fell